BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27528664)

  • 1. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing.
    Hoang ML; Kinde I; Tomasetti C; McMahon KW; Rosenquist TA; Grollman AP; Kinzler KW; Vogelstein B; Papadopoulos N
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9846-51. PubMed ID: 27528664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue.
    Chattopadhyay E; De Sarkar N; Singh R; Ray A; Roy R; Paul RR; Pal M; Ghose S; Ghosh S; Kabiraj D; Banerjee R; Roy B
    Tumour Biol; 2016 Sep; 37(9):11861-11871. PubMed ID: 27055661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.
    Palculict ME; Zhang VW; Wong LJ; Wang J
    Methods Mol Biol; 2016; 1351():3-17. PubMed ID: 26530670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
    Srinivasainagendra V; Sandel MW; Singh B; Sundaresan A; Mooga VP; Bajpai P; Tiwari HK; Singh KK
    Genome Med; 2017 Mar; 9(1):31. PubMed ID: 28356157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing.
    Le Gallo M; Lozy F; Bell DW
    Adv Exp Med Biol; 2017; 943():119-148. PubMed ID: 27910067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.
    Altmüller J; Haenisch B; Kawalia A; Menzen M; Nöthen MM; Fier H; Molderings GJ
    Immunogenetics; 2017 Jun; 69(6):359-369. PubMed ID: 28386644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of low-abundance somatic structural variants in normal cells by high-throughput sequencing.
    Quispe-Tintaya W; Gorbacheva T; Lee M; Makhortov S; Popov VN; Vijg J; Maslov AY
    Nat Methods; 2016 Jul; 13(7):584-6. PubMed ID: 27271197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging patterns of somatic mutations in cancer.
    Watson IR; Takahashi K; Futreal PA; Chin L
    Nat Rev Genet; 2013 Oct; 14(10):703-18. PubMed ID: 24022702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SomaticSeq: An Ensemble and Machine Learning Method to Detect Somatic Mutations.
    Fang LT
    Methods Mol Biol; 2020; 2120():47-70. PubMed ID: 32124311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete sequence of human mitochondrial DNA obtained by combining multiple displacement amplification and next-generation sequencing on a single oocyte.
    Ancora M; Orsini M; Colosimo A; Marcacci M; Russo V; De Santo M; D'Aurora M; Stuppia L; Barboni B; Cammà C; Gatta V
    Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Mar; 28(2):180-181. PubMed ID: 27159691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of next-generation sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders.
    Dames S; Chou LS; Xiao Y; Wayman T; Stocks J; Singleton M; Eilbeck K; Mao R
    J Mol Diagn; 2013 Jul; 15(4):526-34. PubMed ID: 23665194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic structural variation and cancer.
    Tubio JM
    Brief Funct Genomics; 2015 Sep; 14(5):339-51. PubMed ID: 25903743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Individualized Approach for Somatic Variant Discovery.
    Li M; He T; Cao C; Long Q
    Methods Mol Biol; 2020; 2120():11-36. PubMed ID: 32124309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.
    Wei L; Papanicolau-Sengos A; Liu S; Wang J; Conroy JM; Glenn ST; Brese E; Hu Q; Miles KM; Burgher B; Qin M; Head K; Omilian AR; Bshara W; Krolewski J; Trump DL; Johnson CS; Morrison CD
    BMC Med Genomics; 2016 Oct; 9(1):64. PubMed ID: 27756300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between monozygotic twins through next-generation mitochondrial genome sequencing.
    Wang Z; Zhu R; Zhang S; Bian Y; Lu D; Li C
    Anal Biochem; 2015 Dec; 490():1-6. PubMed ID: 26327617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses.
    Aitken SJ; Presneau N; Kalimuthu S; Dileo P; Berisha F; Tirabosco R; Amary MF; Flanagan AM
    Virchows Arch; 2015 Aug; 467(2):203-10. PubMed ID: 25838078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.
    Kalatskaya I; Trinh QM; Spears M; McPherson JD; Bartlett JMS; Stein L
    Genome Med; 2017 Jun; 9(1):59. PubMed ID: 28659176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.